© 2020 MJH Life Sciences and Center for Biosimilars®. All rights reserved.
© 2020 MJH Life Sciences™ and Center for Biosimilars®. All rights reserved.
December 01, 2020
The wearable injector has a failure rate that adds hospitalization costs; therefore, biosimilar pegfilgrastim may hold cost advantages, investigators conclude.
November 30, 2020
November 23, 2020
Meaghan Rose Smith's appointment comes during a time of challenges for the biologics industry.
Pfizer aims to begin marketing Nyvepria in the European Union in the first quarter of 2021.
November 22, 2020
Here are the top 5 biosimilar articles from the American College of Rheumatology (ACR) Convergence 2020.
November 21, 2020
Bincy P. Abraham, MD
Bincy P. Abraham, MD, explains that even when payers allow coverage for biosimilars, providers may still be hesitant to use them.
November 20, 2020
The FDA naming convention and its utility are not well understood, and “poor” biosimilar knowledge may be partly to blame, investigators report.
The rheumatology and gastroenterology biosimilar candidate would enter the lucrative market established by Humira.
Their rituximab biosimilar candidate was advancing in clinical trials for equivalence but represented a business conflict.
Here are the top 5 biosimilar articles for the week of November 16, 2020.
November 19, 2020
Prior to the turmoil of the pandemic, the FDA and CMS were at work on shoring up the biosimilars market, and this work continues on various fronts, a regulatory/policy expert explains.
Plans for a $453.3 million high volume plant and research center were unveiled during an industry forum this week in Republic of Korea.